High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 11, 2013, Pages 2430-2440

  Li, Wei ^a   Liu, Min ^a   Feng, Yuan ^b   Huang, Yan Fei ^c   Xu, Yun Fei ^a   Che, Jian Ping ^a   Wang, Guang Chun ^a   Zheng, Jun Hua ^a  

^a TONGJI UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Bladder urothelial carcinoma; Clinical stage; GSIXX; Histopathologic grade; Jagged2

Indexed keywords

DIBENZAZEPINE; DIBENZAZEPINE DERIVATIVE; JAG2 PROTEIN, HUMAN; JAGGED2; MEMBRANE PROTEIN; SIGNAL PEPTIDE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BLADDER TUMOR; BLADDER UROTHELIAL CARCINOMA; CANCER GRADING; CANCER STAGING; CARCINOMA; CELL PROLIFERATION; CLINICAL STAGE; DISEASE FREE SURVIVAL; DRUG ANTAGONISM; DRUG EFFECT; FEMALE; G2 PHASE CELL CYCLE CHECKPOINT; GSIXX; HISTOPATHOLOGIC GRADE; HUMAN; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; MALE; METABOLISM; METASTASIS; MIDDLE AGED; PATHOLOGY; TIME; TUMOR CELL LINE; TUMOR INVASION; TUMOR RECURRENCE; UPREGULATION; UROTHELIUM; VERY ELDERLY; WESTERN BLOTTING;

BLADDER UROTHELIAL CARCINOMA; CLINICAL STAGE; GSIXX; HISTOPATHOLOGIC GRADE; JAGGED2;

ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CELL PROLIFERATION; DIBENZAZEPINES; DISEASE-FREE SURVIVAL; FEMALE; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KAPLAN-MEIER ESTIMATE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84887181161     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Liou LS. Urothelial cancer biomarkers for de-tection and surveillance. Urology 2006; 67: 25-33; discussion 33-24.
2. Smaldone MC, Jacobs BL, Smaldone AM and Hrebinko RL Jr. Long-term results of selective partial cystectomy for invasive urothelial blad-der carcinoma. Urology 2008; 72: 613-616.
3. Moretti J and Brou C. Ubiquitinations in the notch signaling pathway. Int J Mol Sci 2013; 14: 6359-6381.
4. Espinoza I and Miele L. Notch inhibitors for cancer treatment. Pharmacol Ther 2013; 139: 95-110.
5. Koch U, Lehal R and Radtke F. Stem cells living with a Notch. Development 2013; 140: 689-704.
6. Marignol L, Rivera-Figueroa K, Lynch T and Hollywood D. Hypoxia, notch signalling, and prostate cancer. Nat Rev Urol 2013; 10: 405-413.
7. Capaccione KM and Pine SR. The Notch signal-ing pathway as a mediator of tumor survival. Carcinogenesis 2013; 34: 1420-1430.
8. Shao H, Huang Q and Liu ZJ. Targeting Notch signaling for cancer therapeutic intervention. Adv Pharmacol 2012; 65: 191-234.
9. Leong KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I and Karsan A. Jagged1-mediated Notch activation induces epithelial-to-mesenchymal transition through Slug-induced repression of E-cadherin. J Exp Med 2007; 204: 2935-2948.
10. Wong NK, Fuller M, Sung S, Wong F and Kar-san A. Heterogeneity of breast cancer stem cells as evidenced with Notch-dependent and Notch-independent populations. Cancer Med 2012; 1: 105-113.
11. Song IH, Yeom SW, Heo S, Choi WS, Yang HC, Jheon S, Kim K and Cho S. Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. Eur J Cardiothorac Surg 2013 Jun 27; [Epub ahead of print].
12. Mullendore ME, Koorstra JB, Li YM, Offerhaus GJ, Fan X, Henderson CM, Matsui W, Eberhart CG, Maitra A and Feldmann G. Ligand-depen-dent Notch signaling is involved in tumor initia-tion and tumor maintenance in pancreatic cancer. Clin Cancer Res 2009; 15: 2291-2301.
13. Zhu H, Bhaijee F, Ishaq N, Pepper DJ, Backus K, Brown AS, Zhou X and Miele L. Correlation of Notch1, pAKT and nuclear NF-kappaB expres-sion in triple negative breast cancer. Am J Can-cer Res 2013; 3: 230-239.
14. Yang Y, Ahn YH, Gibbons DL, Zang Y, Lin W Thilaganathan N, Alvarez CA, Moreira DC, Creighton CJ, Gregory PA, Goodall GJ and Kurie JM. The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR- 200-dependent pathway in mice. J Clin Invest 2011; 121: 1373-1385.
15. Vartanian A, Gatsina G, Grigorieva I, Solomko E, Dombrovsky V, Baryshnikov A and Stepano-va E. The involvement of Notch signaling in melanoma vasculogenic mimicry. Clin Exp Med 2013; 13: 201-209.
16. Eble JN, Sauter G, Epstein JI. Pathology and genetics. Tumors of the urinary system and male genital organs. World Health Organiza-tion Classification of Tumors. Lyon: IARC Press, 2004.
17. Greene FL, Page DL, Fleming ID, Fritz A, Charles M. AJCC Cancer Staging Manual. 6th edition. New York, NY: Springer-Verlag, 2002.
18. Euer NI, Kaul S, Deissler H, Mobus VJ, Zeil-linger R and Weidle UH. Identification of L1CAM, Jagged2 and Neuromedin U as ovari-an cancer-associated antigens. Oncol Rep 2005; 13: 375-387.
19. Karamboulas C and Ailles L. Developmental signaling pathways in cancer stem cells of sol-id tumors. Biochim Biophys Acta 2013; 1830: 2481-2495.
20. Xing F, Okuda H, Watabe M, Kobayashi A, Pai SK, Liu W, Pandey PR, Fukuda K, Hirota S, Sugai T, Wakabayshi G, Koeda K, Kashiwaba M, Suzuki K, Chiba T, Endo M, Mo YY and Wa-tabe K. Hypoxia-induced Jagged2 promotes breast cancer metastasis and self-renewal of cancer stem-like cells. Oncogene 2011; 30: 4075-4086.
21. Mittal S, Subramanyam D, Dey D, Kumar RV and Rangarajan A. Cooperation of Notch and Ras/MAPK signaling pathways in human breast carcinogenesis. Mol Cancer 2009; 8: 128.
22. Asnaghi L, Handa JT, Merbs SL, Harbour JW and Eberhart CG. A role for Jag2 in promoting uveal melanoma dissemination and growth. Invest Ophthalmol Vis Sci 2013; 54: 295-306.
23. Mathias RA, Gopal SK and Simpson RJ. Contri-bution of cells undergoing epithelial-mesen-chymal transition to the tumour microenviron-ment. J Proteomics 2013; 78: 545-557.
24. Kim SH, Sehrawat A, Sakao K, Hahm ER and Singh SV. Notch activation by phenethyl iso-thiocyanate attenuates its inhibitory effect on prostate cancer cell migration. PLoS One 2011; 6: e26615.
25. Hong XL, Zhang ZC, Zhao JN and Lu QY. [Inhibi-tory effect of phenylhexyl isothiocyanate on notch signaling of multiple myeloma cells in vitro]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 2011; 19: 940-943.
26. Miyamoto S, Nakanishi M and Rosenberg DW. Suppression of colon carcinogenesis by target-ing Notch signaling. Carcinogenesis 2013 Oct; 34: 2415-2423.
27. Yustein JT, Liu YC, Gao P, Jie C, Le A, Vuica-ross M, Chng WJ, Eberhart CG, Bergsagel PL and Dang CV. Induction of ectopic Myc target gene JAG2 augments hypoxic growth and tumorigen-esis in a human B-cell model. Proc Natl Acad Sci U S A 2010; 107: 3534-3539.